Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02085135 · ClinicalTrials.gov registry record · Phase 3
A Study of Different Titration Schedules of ALKS 5461 in Adults With Major Depressive Disorder (MDD)
A Phase 3 study, sponsored by Alkermes.
- Completed
- Registry status
- Phase 3
- Development phase
- 66
- Enrollment target
NCT02085135: Completed Phase 3 study, sponsored by Alkermes.
NCT02085135 is a Phase 3 study that has completed, run by Alkermes. The registered enrollment target is 66 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (91% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02085135, a Phase 3 study, has completed, sponsored by Alkermes.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 66 participants
- Enrollment target
Study Summary
This is a Phase 3 study designed to evaluate the safety and tolerability of two titration schedules for ALKS 5461.
Interventions
- DRUG ALKS 5461
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66 participants |
| Start Date | 2014-02 |
| Est. Completion | 2014-09 |
| Phase | Phase 3 |
What the finished NCT02085135 record still lists
NCT02085135 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 66 participants, a relatively small participant target, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (91% lower).
The record links to 0 conditions, and to 1 intervention - of which ALKS 5461 is the first listed.
NCT02085135 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02085135 about?
NCT02085135 is a clinical study titled "A Study of Different Titration Schedules of ALKS 5461 in Adults With Major Depressive Disorder (MDD)". This is a Phase 3 study designed to evaluate the safety and tolerability of two titration schedules for ALKS 5461.
What is the current status of trial NCT02085135?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 66 participants. The study started on 2014-02. Estimated completion is 2014-09.
What interventions are being tested in trial NCT02085135?
The interventions under investigation include: ALKS 5461 (DRUG).
Who is sponsoring clinical trial NCT02085135?
This trial is sponsored by Alkermes, which has 66 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02085135's enrollment target sits among peer trials
66 1797th of 2000 higher than 204 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02584244 · 66 participants · Phase 1
Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers
- NCT03067051 · 66 participants · Phase 1
Clinical Study to Assess the Safety and Efficacy of the SpectraCure P18 System
- NCT03754725 · 66 participants · Phase 1
Ferritin and Iron Burden in SAH sIRB
- NCT03875378 · 66 participants · Phase 2
Transdermal Estrogen in Women With Anorexia Nervosa
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia